A talk with Crinetics Chairman Scott Struthers, Ph.D.

During these trying times, work continues, even at a faster pace, for new drugs and therapies for pituitary patients. From the J D Faccinetti, co-founder...

A discussion on telemedicine and pituitary disease

Important changes in telehealth visit regulations provide an excellent opportunity for patients to receive consultations from highly experienced specialists in pituitary disease. Read on! On...

On November 1 organizations around the world mark Acromegaly Day

Patients, advocacy, and healthcare organizations are promoting awareness of the condition around the world. The World Alliance of Pituitary Organizations WAPO Board decided to re-use the...

A note on the importance of awareness

Tell us what is like to live with acromegaly From J D Faccinetti – co-founder and chief editor:  In the awareness business, coming up with new,...

Day time TV tackles acromegaly

Pituitary World News' main goal is to increase awareness of pituitary disease so more people are diagnosed early and properly.  So when a daytime...

A tale of two patients: the biology of different pituitary tumors

Two patients with residual pituitary tumors and their unpredictable differences.

Hello, Pills!

With the recent approval and commercial launch of MYCAPSSA®, Chiasma delivers the first and only oral somatostatin analog to treat acromegaly. The research showed...

A personal story

From Risa Heidt, triathlete, ironwoman  - Marshmallow Clouds -  It was September 2018.  In preparation for my next big cycling event, a 100-mile Century ride...

Help improve acromegaly care around the world.

Acromegaly patients and healthcare providers worldwide can participate in this survey designed to provide information that may help improve quality of life during the...

The amazing possibilities of facial recognition technology.

Dr. Manel Puig Domingo, a leading endocrinologist in Barcelona, is doing important work on facial recognition and biometrics to see if this technology is...

NEWS YOU CAN USE

Articles you may like